Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.43 | N/A |
| PEG Ratio (TTM) | 0.75 | N/A |
| P/S Ratio (TTM) | 0.59 | N/A |
| P/B Ratio (TTM) | 1.22 | N/A |
| P/FCF Ratio (TTM) | 11.33 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.66% | N/A |
| ROE (TTM) | 5.95% | N/A |
| Net Profit Margin (TTM) | 3.10% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 69.72% | 66.70% | N/A |
| Revenue | -1.62% | 73.48% | N/A |
| Net Income | 64.40% | 66.72% | N/A |
| Cash Flow | 32.19% | 113.39% | N/A |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.93 | N/A |
| Quick Ratio (TTM) | 1.46 | N/A |
| D/E Ratio (TTM) | 0.58 | N/A |
| Interest Coverage (TTM) | 2.97 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.94 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |